Cognoptix is pioneering a new way to see Alzheimer's disease (AD): a low-cost, practical and non-invasive eye scan that detects beta-amyloid deposits in the lens. Amyloid is the earliest biomarker of AD, and our system can detect it years or decades before amyloid appears in the brain.
Location: United States, Massachusetts, Marlborough
Employees: 11-50
Total raised: $30M
Founded date: 2019
Investors 4
| Date | Name | Website |
| - | Aubrey Cap... | aubreycapi... |
| - | New York A... | newyorkang... |
| - | Maine Ange... | maineangel... |
| - | Inventages | inventages... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 01.10.2014 | Series C | $15M | - |
| 01.10.2014 | Series D | $15M | - |
Mentions in press and media 11
| Date | Title | Description | Source |
| 03.05.2023 | AXEPTIO, A LEADER IN RESPECTFUL INTERNET USER CONSENT MANAGE... | Paris, May 3, 2023 - Since 2017, Axeptio has been developing a consent management platform aimed at ... | isai.vc/ne... |
| 23.12.2014 | Sick of immunotherapy? These biotech/medtech startups are do... | ZipLine Medical Stapling up skin post-surgery is pretty much the norm to quickly seal up wounds, bu... | medcitynew... |
| 03.10.2014 | Startup aims to diagnose Alzheimer’s through simple eye test... | “If binding increases over time, a positive diagnosis can be made, enabling clinicians to track the ... | medcitynew... |
| 01.10.2014 | Cognoptix Raises Over $15M in Series C | ACTON, MA, Emerging medical device company has closed the first tranche of a Series D round of fin... | vcnewsdail... |
| 01.10.2014 | Cognoptix Closes $15M Series D Financing | Cognoptix, an Acton, MA-based emerging medical device company, closed the first tranche of a $15m Se... | finsmes.co... |
| 30.09.2014 | Cognoptix Raises over $15 Million to Fund Pivotal Clinical T... | Over-subscribed Series D round co-led by Alopexx Enterprises LLC and Inventages “Our clinical trial ... | venturebea... |
| 16.07.2013 | One to watch: Medical device company says eye test can diagn... | PET imaging is approved to detect these kinds of plaques in living patients, but a noninvasive, low-... | medcitynew... |
| - | Learn from a pro: Strategies to interest angels and VCs in a... | Paul Hartung, CEO of Cognoptix, Inc., a startup that has created a drug-device that could diagnose A... | medcitynew... |
| - | One to watch: Medical device company says eye test can diagn... | Cognoptix, Inc. claims to have created a working, in-office, non-invasive eye-scan that detects Alzh... | medcitynew... |
| - | Sick of immunotherapy? These biotech/medtech startups are do... | We’re in the era of immunotherapy, of monoclonal antibodies and anti-inflammation drugs and personal... | medcitynew... |
Show more